Morgan Stanley analyst Eric Serotta raised the firm’s price target on Philip Morris (PM) to $155 from $140 and keeps an Overweight rating on the shares. Stronger than expected Q4 results and ...

Now, she must scramble to find another safe place for her sexual health screenings and Pre-Exposure Prophylaxis (PrEP) - her regular defence against rampant HIV. Image: South Africa is home to one ...

Analysis Reveals an Additional Mechanism Behind Statin Therapy's Heart-Related Benefits in People With HIV Dec. 11, 2024 — Investigators who previously found that a daily statin pill helps ...

Hospital CEO Dr Phillip Kirwa said some of the staff who were attached to Ampath clinics will continue to offer care and support to the patients mostly in the Western Kenya region. “Patients ...

Citi analyst Simon Hales raised the firm’s price target on Philip Morris (PM) to $163 from $147 and keeps a Buy rating on the shares, citing the “impressive strong end to 2024 and stronger ...

UBS analyst Faham Baig raised the firm’s price target on Philip Morris (PM) to $120 from $105 and keeps a Sell rating on the shares. Philip Morris guided to another year of volume growth and ...

Feb 6 (Reuters) - Cigarette giant Philip Morris International (PM.N), opens new tab on Thursday forecast better-than-expected profit growth for 2025, with estimations for its fast-growing nicotine ...

Stifel Nicolaus analyst Matthew Smith, CFA maintained a Buy rating on Philip Morris (PM – Research Report) today and set a price target of $160.00. The company’s shares closed yesterday at ...

After Donald Trump gave orders that US would recognise only two sexes, references to LGBT health, HIV, and information on certain vaccines from federal websites have been removed from CDC websites.

Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic. Confronting the HIV Epidemic: There's an App ...

A U.S. freeze on foreign aid for Indonesia could strain the Asian country's efforts to fight against HIV and tuberculosis, which replaced COVID-19 to become the top cause of infectious disease ...

Clinical trials testing efficacy of novel HIV treatments rely on analytical treatment interruption (ATI). Using data from 24 prospective studies, the authors here show that the virus becomes ...